WT1 peptide vaccine study after "Adoptive transfer of lymphocytes transduced with WT1-specific TCR gene"
Phase of Trial: Phase I
Latest Information Update: 10 Nov 2016
At a glance
- Drugs WT1 TCR-transduced T cells-Takara Bio (Primary) ; Montanide ISA-51
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions; Pharmacodynamics
- 05 Nov 2016 Status changed from suspended to discontinued.
- 06 May 2016 Status changed from recruiting to suspended.
- 07 May 2015 New trial record